Variant report

Variant	nsv892069
Chromosome Location	chr9:2600836-2631738
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr9:2602546-2603254	GM12878	blood:	n/a	n/a
2	ATF2	chr9:2616716-2617355	GM12878	blood:	n/a	n/a
3	ATF2	chr9:2602570-2603228	GM12878	blood:	n/a	n/a
4	ATF3	chr9:2623434-2623749	H1-hESC	embryonic stem cell:	n/a	chr9:2623474-2623494
5	BACH1	chr9:2621410-2621682	H1-hESC	embryonic stem cell:	n/a	n/a
6	BATF	chr9:2602261-2602493	GM12878	blood:	n/a	n/a
7	BATF	chr9:2602596-2603221	GM12878	blood:	n/a	n/a
8	BATF	chr9:2617015-2617371	GM12878	blood:	n/a	n/a
9	BATF	chr9:2621265-2621528	GM12878	blood:	n/a	n/a
10	BATF	chr9:2617020-2617395	GM12878	blood:	n/a	n/a
11	BATF	chr9:2617423-2617686	GM12878	blood:	n/a	n/a
12	BATF	chr9:2617416-2617678	GM12878	blood:	n/a	n/a
13	BATF	chr9:2621293-2621482	GM12878	blood:	n/a	n/a
14	BATF	chr9:2602600-2603204	GM12878	blood:	n/a	n/a
15	BCL11A	chr9:2616999-2617318	GM12878	blood:	n/a	chr9:2617113-2617122
16	BCL11A	chr9:2616785-2617375	GM12878	blood:	n/a	chr9:2617113-2617122
17	BCL11A	chr9:2602578-2603142	GM12878	blood:	n/a	n/a
18	BCL11A	chr9:2602637-2602848	GM12878	blood:	n/a	n/a
19	BCL3	chr9:2601903-2602131	GM12878	blood:	n/a	n/a
20	BCL3	chr9:2602568-2602933	GM12878	blood:	n/a	n/a
21	BHLHE40	chr9:2623320-2623869	HepG2	liver:	n/a	chr9:2623484-2623493 chr9:2623485-2623494 chr9:2623485-2623494
22	BHLHE40	chr9:2621256-2621931	GM12878	blood:	n/a	chr9:2621658-2621674 chr9:2621798-2621814 chr9:2621583-2621599 chr9:2621799-2621815
23	BHLHE40	chr9:2623345-2623847	A549	lung:	n/a	chr9:2623484-2623493 chr9:2623485-2623494 chr9:2623485-2623494
24	BHLHE40	chr9:2621241-2621747	HepG2	liver:	n/a	chr9:2621658-2621674 chr9:2621583-2621599
25	BHLHE40	chr9:2621446-2621718	K562	blood:	n/a	chr9:2621658-2621674 chr9:2621583-2621599
26	BHLHE40	chr9:2622428-2622971	GM12878	blood:	n/a	chr9:2622781-2622797 chr9:2622746-2622762
27	BHLHE40	chr9:2602783-2603189	GM12878	blood:	n/a	n/a
28	BHLHE40	chr9:2623210-2623849	GM12878	blood:	n/a	chr9:2623484-2623493 chr9:2623485-2623494 chr9:2623485-2623494
29	BRCA1	chr9:2623380-2623503	HepG2	liver:	n/a	n/a
30	CCNT2	chr9:2621423-2621804	K562	blood:	n/a	n/a
31	CEBPB	chr9:2621303-2621449	HepG2	liver:	n/a	n/a
32	CEBPB	chr9:2609838-2609957	H1-hESC	embryonic stem cell:	n/a	chr9:2609864-2609875
33	CEBPB	chr9:2621124-2621632	A549	lung:	n/a	n/a
34	CEBPB	chr9:2621158-2621559	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr9:2624354-2624556	H1-hESC	embryonic stem cell:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
36	CEBPB	chr9:2621212-2621491	K562	blood:	n/a	n/a
37	CEBPB	chr9:2611134-2611431	A549	lung:	n/a	chr9:2611265-2611276
38	CEBPB	chr9:2621155-2621549	IMR90	lung:	n/a	n/a
39	CEBPB	chr9:2602595-2603130	MCF-7	breast:	n/a	chr9:2602944-2602955
40	CEBPB	chr9:2624289-2624719	A549	lung:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
41	CEBPB	chr9:2602689-2603252	GM12878	blood:	n/a	chr9:2602944-2602955
42	CEBPB	chr9:2621175-2621530	HepG2	liver:	n/a	n/a
43	CEBPB	chr9:2624344-2624623	Hela-S3	cervix:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
44	CEBPB	chr9:2621194-2621559	MCF-7	breast:	n/a	n/a
45	CEBPB	chr9:2611109-2611418	HepG2	liver:	n/a	chr9:2611265-2611276
46	CEBPB	chr9:2611122-2611379	H1-hESC	embryonic stem cell:	n/a	chr9:2611265-2611276
47	CEBPB	chr9:2624317-2624652	K562	blood:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
48	CEBPB	chr9:2611088-2611458	IMR90	lung:	n/a	chr9:2611265-2611276
49	CEBPB	chr9:2609715-2610006	HepG2	liver:	n/a	chr9:2609864-2609875
50	CEBPB	chr9:2609739-2610007	K562	blood:	n/a	chr9:2609864-2609875

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:2623684-2623734	HepG2	liver:	n/a
2	chr9:2626347-2626397	CMK	blood:	n/a
3	chr9:2621379-2621429	ECC-1	luminal epithelium:	n/a
4	chr9:2622584-2622634	NT2-D1	testis:	n/a
5	chr9:2621918-2621968	SK-N-MC	brain:	n/a
6	chr9:2621379-2621429	HCF	heart:	n/a
7	chr9:2621379-2621429	NHDF-neo	bronchial:	n/a
8	chr9:2621094-2621144	HMEC	breast:	n/a
9	chr9:2621379-2621429	MCF10A-Er-Src	breast:	n/a
10	chr9:2621094-2621144	HAEpiC	amniotic membrane:	n/a
11	chr9:2623562-2623612	PANC-1	pancreas:	n/a
12	chr9:2623146-2623196	HUVEC	blood vessel:	n/a
13	chr9:2626347-2626397	AG09309	skin:	n/a
14	chr9:2621918-2621968	MCF10A-Er-Src	breast:	n/a
15	chr9:2622584-2622634	AG04449	skin:	fetal
16	chr9:2623146-2623196	HMEC	breast:	n/a
17	chr9:2626347-2626397	HMEC	breast:	n/a
18	chr9:2626347-2626397	GM12891	blood:	n/a
19	chr9:2622584-2622634	PrEC	prostate:	n/a
20	chr9:2619314-2619364	PrEC	prostate:	n/a
21	chr9:2621918-2621968	AG09319	gingival:	n/a
22	chr9:2621918-2621968	SAEC	small airway:	n/a
23	chr9:2621918-2621968	NH-A	brain:	n/a
24	chr9:2621918-2621968	AG04450	lung:	fetal
25	chr9:2623146-2623196	T-47D	breast:	n/a
26	chr9:2622584-2622634	HCF	heart:	n/a
27	chr9:2619314-2619364	NHBE	bronchial:	n/a
28	chr9:2621918-2621968	RPTEC	kidney:	n/a
29	chr9:2623146-2623196	CMK	blood:	n/a
30	chr9:2622584-2622634	HCT-116	colon:	n/a
31	chr9:2622584-2622634	SK-N-SH_RA	brain:	n/a
32	chr9:2623146-2623196	AG09309	skin:	n/a
33	chr9:2626347-2626397	GM12892	blood:	n/a
34	chr9:2621918-2621968	ProgFib	skin:	n/a
35	chr9:2619314-2619364	NH-A	brain:	n/a
36	chr9:2623146-2623196	HNPCEpiC	eye:	n/a
37	chr9:2623562-2623612	GM12891	blood:	n/a
38	chr9:2622584-2622634	BE2_C	brain:	n/a
39	chr9:2623146-2623196	GM19239	blood:	n/a
40	chr9:2621094-2621144	Jurkat	blood:	n/a
41	chr9:2621094-2621144	HRE	kidney:	n/a
42	chr9:2621094-2621144	K562	blood:	n/a
43	chr9:2623684-2623734	SK-N-MC	brain:	n/a
44	chr9:2621094-2621144	GM06990	blood:	n/a
45	chr9:2622584-2622634	AG09319	gingival:	n/a
46	chr9:2626347-2626397	NH-A	brain:	n/a
47	chr9:2621094-2621144	SK-N-SH	brain:	n/a
48	chr9:2619314-2619364	Hela-S3	cervix:	n/a
49	chr9:2621379-2621429	NB4	blood:	n/a
50	chr9:2621094-2621144	NT2-D1	testis:	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:2624771..2627181-chr9:2629101..2631938,2	MCF-7	breast:
2	chr9:2617041..2619621-chr9:2621235..2624621,3	MCF-7	breast:
3	chr9:2598816..2601731-chr9:2621895..2624839,2	MCF-7	breast:
4	chr9:2613768..2615804-chr9:2618805..2621446,2	K562	blood:
5	chr9:2620987..2624573-chr9:2639977..2643677,3	MCF-7	breast:
6	chr10:27845465..27846029-chr9:2600388..2600977,2	MCF-7	breast:
7	chr9:2228114..2228719-chr9:2625246..2626097,2	MCF-7	breast:
8	chr9:2622798..2625667-chr9:2640741..2642429,2	K562	blood:
9	chr9:2616577..2619117-chr9:2619974..2622873,2	MCF-7	breast:
10	chr9:2620203..2621987-chr9:2627062..2629533,2	MCF-7	breast:
11	chr9:2611403..2613342-chr9:2621748..2624247,2	MCF-7	breast:
12	chr9:2624771..2627181-chr9:2629101..2631938,2	MCF-7	breast:
13	chr9:2621566..2623636-chr9:2638581..2641950,3	MCF-7	breast:
14	chr9:2255030..2255773-chr9:2600478..2601011,2	MCF-7	breast:
15	chr9:2613986..2615496-chr9:2621852..2624711,2	MCF-7	breast:
16	chr9:2621586..2624495-chr9:2626376..2628188,2	K562	blood:
17	chr9:2618162..2620045-chr9:2621820..2624612,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KIAA0020-1	chr9:2622100-2622373	NR_015375
2	lnc-KIAA0020-1	chr9:2622100-2622373	ENSG00000236404
3	lnc-KIAA0020-1	chr9:2619998-2621792	NONHSAT130002
4	lnc-KIAA0020-1	chr9:2611229-2611526	l_3727_chr9:2411588-2611526_ovary
5	lnc-KIAA0020-1	chr9:2621229-2621413	ENSG00000236404
6	lnc-KIAA0020-1	chr9:2621229-2621413	ENSG00000236404.4

Variant related genes	Relation type
ENSG00000236404	TF binding region
VLDLR	TF binding region
ENSG00000236404	CpG island
VLDLR	CpG island
ENSG00000236404	chromatin interactions
ENSG00000147852	chromatin interactions
SPRED1	miRNA target sites

Extended variants
information (count: 1430 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:1430 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10757571	chr9:2600836-2600837	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs543788025	chr9:2600858-2600859	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs542511040	chr9:2600865-2600866	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs140791548	chr9:2600992-2600993	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs142368678	chr9:2600995-2600996	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs150821611	chr9:2600997-2600998	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs555284746	chr9:2600999-2601000	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs528217082	chr9:2601002-2601003	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs548354043	chr9:2601070-2601071	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs558640279	chr9:2601083-2601084	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs190210049	chr9:2601092-2601093	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs115004911	chr9:2601146-2601147	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs550569804	chr9:2601186-2601187	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs575421327	chr9:2601197-2601198	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs368874108	chr9:2601198-2601199	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs570771434	chr9:2601216-2601217	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs181912565	chr9:2601234-2601235	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs559040607	chr9:2601274-2601275	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs187289090	chr9:2601284-2601285	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs566170996	chr9:2601307-2601308	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs534841548	chr9:2601326-2601327	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs550451377	chr9:2601383-2601384	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs570519398	chr9:2601407-2601408	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs139277577	chr9:2601510-2601511	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs12336420	chr9:2601511-2601512	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs577122454	chr9:2601512-2601513	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs191035871	chr9:2601527-2601528	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs146758650	chr9:2601543-2601544	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs528171818	chr9:2601572-2601573	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs532547009	chr9:2601581-2601582	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs117384550	chr9:2601584-2601585	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs530582022	chr9:2601605-2601606	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs12682902	chr9:2601613-2601614	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs7024342	chr9:2601615-2601616	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs181922374	chr9:2601638-2601639	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs374285299	chr9:2601646-2601647	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs146494681	chr9:2601647-2601648	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs566107960	chr9:2601659-2601660	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs528956398	chr9:2601677-2601678	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs12684208	chr9:2601696-2601697	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs554730758	chr9:2601702-2601703	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs536871398	chr9:2601727-2601728	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs537201076	chr9:2601738-2601739	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs143100808	chr9:2601741-2601742	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs12682918	chr9:2601753-2601754	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs546120985	chr9:2601754-2601755	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs148193134	chr9:2601786-2601787	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs572718462	chr9:2601813-2601814	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs140096064	chr9:2601830-2601831	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs367790620	chr9:2601832-2601833	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Gastric cancer	16715143	CNVD
Glioblastoma multiforme	22286061	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	21373258	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Schizophrenia	23813976	CNVD
Ovarian cancer	22355333	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Schizophrenia	20967226	CNVD
Maculopathy	22355348	CNVD
Ovarian cancer	21781307	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:910 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:2594000-2610400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr9:2597800-2613800	Weak transcription	Psoas Muscle	Psoas
3	chr9:2598200-2602600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
4	chr9:2599000-2602600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
5	chr9:2599000-2610600	Weak transcription	Ovary	ovary
6	chr9:2600400-2602400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr9:2600800-2601000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr9:2600800-2601400	Enhancers	Fetal Heart	heart
9	chr9:2601000-2613600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
10	chr9:2601400-2602400	Weak transcription	Fetal Heart	heart
11	chr9:2602000-2603000	Enhancers	GM12878-XiMat	blood
12	chr9:2602000-2603800	Enhancers	Hela-S3	cervix
13	chr9:2602400-2602800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr9:2602400-2603200	Enhancers	Skeletal Muscle Female	skeletal muscle
15	chr9:2602400-2603800	Enhancers	Fetal Heart	heart
16	chr9:2602600-2603000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr9:2602600-2603200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
18	chr9:2602600-2603200	Enhancers	HSMMtube	muscle
19	chr9:2602600-2603400	Enhancers	Fetal Lung	lung
20	chr9:2602800-2603600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
21	chr9:2603000-2603400	Enhancers	Skeletal Muscle Male	skeletal muscle
22	chr9:2603400-2613600	Weak transcription	Fetal Lung	lung
23	chr9:2603600-2603800	Enhancers	ES-I3 Cell Line	embryonic stem cell
24	chr9:2603600-2603800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr9:2603800-2607800	Weak transcription	Fetal Heart	heart
26	chr9:2603800-2610200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
27	chr9:2607800-2609000	Enhancers	Fetal Heart	heart
28	chr9:2608000-2608400	Enhancers	Right Atrium	heart
29	chr9:2608200-2608400	Enhancers	HUES64 Cell Line	embryonic stem cell
30	chr9:2608400-2608800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr9:2608600-2609400	Weak transcription	Right Atrium	heart
32	chr9:2608800-2612000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
33	chr9:2609000-2611400	Weak transcription	Fetal Heart	heart
34	chr9:2609600-2615200	Weak transcription	Brain Substantia Nigra	brain
35	chr9:2610200-2610600	Enhancers	Primary neutrophils fromperipheralblood	blood
36	chr9:2610200-2611600	Enhancers	HUES48 Cell Line	embryonic stem cell
37	chr9:2610200-2611600	Enhancers	HUES64 Cell Line	embryonic stem cell
38	chr9:2610200-2611800	Enhancers	ES-I3 Cell Line	embryonic stem cell
39	chr9:2610400-2614000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr9:2610600-2611000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
41	chr9:2610600-2611200	Enhancers	Ovary	ovary
42	chr9:2610600-2611400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr9:2610600-2615800	Enhancers	iPS-18 Cell Line	embryonic stem cell
44	chr9:2610800-2611200	Enhancers	Placenta	Placenta
45	chr9:2610800-2611400	Bivalent Enhancer	HSMMtube	muscle
46	chr9:2610800-2611600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
47	chr9:2611000-2611200	Enhancers	H1 Cell Line	embryonic stem cell
48	chr9:2611000-2611200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
49	chr9:2611000-2611200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr9:2611000-2611400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links